Churchill Management Raised By $465,711 Its Abbott Labs Com (ABT) Holding; Tortoise Capital Advisors Has Raised Enterprise Prods Partners L (EPD) Stake

February 20, 2018 - By Nellie Frank

Churchill Management Corp increased Abbott Labs Com (ABT) stake by 53.11% reported in 2017Q3 SEC filing. Churchill Management Corp acquired 8,787 shares as Abbott Labs Com (ABT)’s stock declined 3.42%. The Churchill Management Corp holds 25,331 shares with $1.35M value, up from 16,544 last quarter. Abbott Labs Com now has $104.73 billion valuation. The stock increased 1.13% or $0.67 during the last trading session, reaching $60.17. About 7.85M shares traded or 12.40% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 20, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Tortoise Capital Advisors Llc increased Enterprise Prods Partners L (EPD) stake by 5.02% reported in 2017Q3 SEC filing. Tortoise Capital Advisors Llc acquired 2.09M shares as Enterprise Prods Partners L (EPD)’s stock declined 6.06%. The Tortoise Capital Advisors Llc holds 43.76M shares with $1.14 billion value, up from 41.67M last quarter. Enterprise Prods Partners L now has $57.07 billion valuation. The stock decreased 1.42% or $0.38 during the last trading session, reaching $26.41. About 4.82M shares traded. Enterprise Products Partners L.P. (NYSE:EPD) has declined 0.18% since February 20, 2017 and is downtrending. It has underperformed by 16.88% the S&P500.

Churchill Management Corp decreased Waste Mgmt Inc Del Com (NYSE:WM) stake by 15,010 shares to 259,840 valued at $20.34 million in 2017Q3. It also reduced Amazon Com Inc Com (NASDAQ:AMZN) stake by 14,406 shares and now owns 25,224 shares. Gallagher Arthur J & Co Com (NYSE:AJG) was reduced too.

Since September 22, 2017, it had 0 insider buys, and 7 sales for $31.71 million activity. 96,603 shares valued at $5.43 million were sold by Salvadori Daniel Gesua Sive on Monday, October 23. 52,700 shares were sold by Contreras Jaime, worth $2.74 million on Friday, September 22. The insider Blaser Brian J sold 27,733 shares worth $1.73M. Another trade for 42,665 shares valued at $2.69 million was sold by Ford Robert B. 227,412 shares valued at $14.27 million were sold by Fussell Stephen R on Tuesday, January 30.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories has $90 highest and $4 lowest target. $63.81’s average target is 6.05% above currents $60.17 stock price. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The company was downgraded on Thursday, September 28 by Northland Capital. As per Saturday, August 29, the company rating was maintained by BTIG Research. The stock has “Buy” rating by Jefferies on Tuesday, June 14. The firm has “Outperform” rating given on Thursday, January 25 by Wells Fargo. The firm earned “Buy” rating on Saturday, August 29 by Deutsche Bank. The stock has “Buy” rating by Argus Research on Friday, February 5. The rating was upgraded by JP Morgan on Tuesday, January 2 to “Overweight”. The company was maintained on Thursday, October 19 by RBC Capital Markets. The rating was maintained by Barclays Capital with “Overweight” on Thursday, January 25. As per Thursday, October 19, the company rating was maintained by Morgan Stanley.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Usca Ria Lc invested in 17,385 shares or 0.11% of the stock. Clark Cap Mngmt Group Inc owns 13,493 shares or 0.02% of their US portfolio. Peoples Financial Services holds 0.67% or 22,228 shares. Guyasuta Invest Advsr Inc accumulated 0.13% or 20,855 shares. Allen Inv Management Limited Liability Corporation invested in 0.03% or 11,627 shares. Tcw has 19,360 shares. Natixis Asset Mgmt has 0.08% invested in Abbott Laboratories (NYSE:ABT) for 17,459 shares. Peapack Gladstone Financial Corp reported 0.3% of its portfolio in Abbott Laboratories (NYSE:ABT). Barr E S stated it has 6,333 shares or 0.04% of all its holdings. Duff Phelps Invest Management Company has 0.01% invested in Abbott Laboratories (NYSE:ABT). Martin & Comm Tn holds 0.98% in Abbott Laboratories (NYSE:ABT) or 56,410 shares. Summit Secs Grp Incorporated Limited Liability Co invested 0.29% in Abbott Laboratories (NYSE:ABT). Spark Invest Mngmt Limited Liability Company holds 4,000 shares or 0.01% of its portfolio. Clearbridge Invs Limited Company has invested 0% in Abbott Laboratories (NYSE:ABT). Sky Inv Group Inc Ltd Liability invested in 107,212 shares or 2.34% of the stock.

Among 24 analysts covering Enterprise Products Partners LP (NYSE:EPD), 23 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. Enterprise Products Partners LP has $38 highest and $29 lowest target. $32.25’s average target is 22.11% above currents $26.41 stock price. Enterprise Products Partners LP had 52 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was initiated by Evercore on Friday, September 16 with “Buy”. BMO Capital Markets maintained Enterprise Products Partners L.P. (NYSE:EPD) rating on Tuesday, July 11. BMO Capital Markets has “Buy” rating and $3300 target. BMO Capital Markets maintained Enterprise Products Partners L.P. (NYSE:EPD) on Thursday, October 12 with “Buy” rating. The firm has “Buy” rating given on Friday, October 13 by Mizuho. The stock of Enterprise Products Partners L.P. (NYSE:EPD) earned “Buy” rating by Jefferies on Friday, September 1. The rating was maintained by Citigroup with “Buy” on Tuesday, April 19. As per Wednesday, November 16, the company rating was initiated by Ladenburg Thalmann. The stock of Enterprise Products Partners L.P. (NYSE:EPD) earned “Outperform” rating by Macquarie Research on Monday, April 24. The company was maintained on Wednesday, August 31 by Wunderlich. The firm has “Overweight” rating given on Friday, April 1 by Piper Jaffray.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: